Protea Biosciences Group Analysis
Protea Biosciences Group is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Protea Biosciences otc analysis is to determine its intrinsic value, which is an estimate of what Protea Biosciences Group is worth, separate from its market price. There are two main types of Protea Biosciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Protea Biosciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Protea Biosciences' stock to identify patterns and trends that may indicate its future price movements.
The Protea Biosciences otc bb equity is traded in the USA on OTCBB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Protea Biosciences is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Protea OTC BB Equity trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Protea Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Protea |
Protea OTC BB Equity Analysis Notes
About 50.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 6.41. Protea Biosciences had not issued any dividends in recent years. The entity had a split on the 16th of October 2017. Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The quote for Protea Biosciences Group is listed on Over-The-Counter Bulletin Board (i.e., OTCBB), and the company does not need to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Protea Biosciences Group contact Stephen Turner at 304-292-2226 or learn more at http://www.proteabio.com.Protea Biosciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Protea Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Protea Biosciences Group or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Protea Biosciences is not yet fully synchronised with the market data | |
| Protea Biosciences has some characteristics of a very speculative penny stock | |
| Protea Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 10.93 M in liabilities. Protea Biosciences has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Protea Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Protea Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Protea Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Protea to invest in growth at high rates of return. When we think about Protea Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.07 M. Net Loss for the year was (24.12 M) with profit before overhead, payroll, taxes, and interest of 741.03 K. | |
| Protea Biosciences Group currently holds about 82.65 K in cash with (3.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 50.0% of the company outstanding shares are owned by corporate insiders |
Protea Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 281.21 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Protea Biosciences's market, we take the total number of its shares issued and multiply it by Protea Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc bb equity analysis tools, you can find out how much better you can do when adding Protea Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Protea Biosciences information on this page should be used as a complementary analysis to other Protea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Protea OTC BB Equity
If you are still planning to invest in Protea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Protea Biosciences' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |